Amélie Lothe

707 total citations
22 papers, 544 citations indexed

About

Amélie Lothe is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Amélie Lothe has authored 22 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 11 papers in Cellular and Molecular Neuroscience and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Amélie Lothe's work include Epilepsy research and treatment (12 papers), Neuroscience and Neuropharmacology Research (6 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Amélie Lothe is often cited by papers focused on Epilepsy research and treatment (12 papers), Neuroscience and Neuropharmacology Research (6 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Amélie Lothe collaborates with scholars based in France, United States and United Kingdom. Amélie Lothe's co-authors include Philippe Ryvlin, Nicolas Costes, Adrien Didelot, Alexander Hammers, François Mauguı̀ere, Mohamed Saoud, Carolina Ciumas, Frank Gilliam, Isabelle Merlet and Sandrine Bouvard and has published in prestigious journals such as NeuroImage, Brain and Neurology.

In The Last Decade

Amélie Lothe

21 papers receiving 530 citations

Peers

Countries citing papers authored by Amélie Lothe

Since Specialization

Citations

This map shows the geographic impact of Amélie Lothe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amélie Lothe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amélie Lothe more than expected).

Fields of papers citing papers by Amélie Lothe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amélie Lothe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amélie Lothe. The network helps show where Amélie Lothe may publish in the future.

Co-authorship network of co-authors of Amélie Lothe

This figure shows the co-authorship network connecting the top 25 collaborators of Amélie Lothe. A scholar is included among the top collaborators of Amélie Lothe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amélie Lothe. Amélie Lothe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long‐term safety and effectiveness of fenfluramine in children and adults with Dravet syndrome 2025 ·Epilepsia ·Ingrid E. Scheffer, Rima Nabbout, Lieven Lagae, Orrin Devinsky, Stéphane Auvin, Elizabeth A. Thiele, Elaine Wirrell, Tilman Polster, Nicola Specchio, Milka Pringsheim, (unknown), Michael Lock, Mélanie Langlois, (unknown), Amélie Lothe, Joseph Sullivan	1
2	Interim Results of the US Fenfluramine Oral Solution Cardiovascular Safety Registry Study (S12.002) 2025 ·Neurology ·Almasa Bass, Diego Morita, (unknown), (unknown), (unknown), (unknown), Amélie Lothe, Jenna Roberts, N C Nayak	1
3	Comprehensive scoping review of fenfluramine's role in managing generalized tonic–clonic seizures in developmental and epileptic encephalopathies 2024 ·Epilepsia ·António Gil‐Nagel, J. Helen Cross, Orrin Devinsky, Berten Ceulemans, Lieven Lagae, Kelly G. Knupp, An‐Sofie Schoonjans, Philippe Ryvlin, Elizabeth A. Thiele, (unknown), Amélie Lothe, Rima Nabbout	4
4	GABAergic inhibition shapes behavior and neural dynamics in human visual working memory 2024 ·Cerebral Cortex ·Jan Kujala, Carolina Ciumas, Julien Jung, (unknown), Françoise Lecaignard, Amélie Lothe, Romain Bouet, Philippe Ryvlin, Karim Jerbi	3
5	Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome 2023 ·Epilepsia Open ·John Cha, Gregory Filatov, (unknown), Arnold R. Gammaitoni, Amélie Lothe, (unknown)	10
6	Fenfluramine Treatment Is Associated With Improvement in Everyday Executive Function in Adults With Lennox-Gastaut Syndrome: Post-Hoc Analysis of Dose Effects From a Phase 3 Trial Rationale (P11-1.001) 2023 ·Neurology ·(unknown), Peter Κ. Isquith, Kelly G. Knupp, Joseph Sullivan, Rima Nabbout, António Gil‐Nagel, Ingrid E. Scheffer, Stéphane Auvin, J. Helen Cross, Renzo Guerrini, R.S. Roth, Gérard A. Gioia, Amélie Lothe, (unknown)	5
7	Fenfluramine treatment for Dravet syndrome: Caregiver- and clinician-reported benefits on the quality of life of patients, caregivers, and families living in Germany, Spain, Italy, and the United Kingdom 2023 ·Epilepsy Research ·Mark P. Jensen, Arnold R. Gammaitoni, Rana Salem, (unknown), Amélie Lothe, Dagmar Amtmann	13
8	EEG parameters as endpoints in epilepsy clinical trials - An expert panel opinion paper 2022 ·Epilepsy Research ·Jeffrey Buchhalter, Caroline Neuray, Jocelyn Y. Cheng, O’Neill D’Cruz, Alexandre Datta, Dennis Dlugos, Jacqueline A. French, Dietrich Haubenberger, Joseph Hulihan, Pavel Klein, Robert W. Komorowski, Lynn D. Kramer, Amélie Lothe, Rima Nabbout, Emilio Perucca, Peter van der Ark	8
9	An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real‐world practice setting: A report from the Fenfluramine European Early Access Program 2022 ·Epilepsia Open ·Renzo Guerrini, Nicola Specchio, Ángel Aledo‐Serrano, Milka Pringsheim, Francesca Darra, (unknown), António Gil‐Nagel, Tilman Polster, Sameer M. Zuberi, Amélie Lothe, Arnold R. Gammaitoni, Adam Strzelczyk	29
10	Gamma oscillations in V1 are correlated with GABAA receptor density: A multi-modal MEG and Flumazenil-PET study 2015 ·Scientific Reports ·Jan Kujala, Julien Jung, (unknown), Françoise Lecaignard, Amélie Lothe, Romain Bouet, Carolina Ciumas, Philippe Ryvlin, Karim Jerbi	75
11	White matter development in children with benign childhood epilepsy with centro-temporal spikes 2014 ·Brain ·Carolina Ciumas, (unknown), (unknown), Vania Herbillon, Agathe Laurent, Amélie Lothe, Rolf A. Heckemann, Julitta de Bellescize, Eleni Panagiotakaki, Salem Hannoun, Dominique Sappey‐Marinier, Alexandra Montavont, Karine Ostrowsky‐Coste, Nathalie Bedoin, Philippe Ryvlin	72
12	Effects of Aripiprazole, Risperidone, and Olanzapine on 5-HT1A Receptors in Patients With Schizophrenia 2012 ·Journal of Clinical Psychopharmacology ·Jérôme Lerond, Amélie Lothe, Philippe Ryvlin, Sandrine Bouvard, Thierry d’Amato, Carolina Ciumas, J Daléry, Emmanuel Poulet, Mohamed Saoud	16
13	5-HT1A receptor binding changes in patients with major depressive disorder before and after antidepressant treatment: A pilot [18F]MPPF positron emission tomography study 2012 ·Psychiatry Research Neuroimaging ·Amélie Lothe, Mohamed Saoud, Sandrine Bouvard, Jérôme Redouté, Jérôme Lerond, Philippe Ryvlin	10
14	Candidate Socioemotional Remediation Program for Individuals with Intellectual Disability 2012 ·American Journal on Intellectual and Developmental Disabilities ·Bronwyn Glaser, Amélie Lothe, (unknown), Daniel Dukes, (unknown), Jérôme Redouté, Stéphan Eliez	19
15	Voxel-Based Analysis of Asymmetry Index Maps Increases the Specificity of ¹⁸F-MPPF PET Abnormalities for Localizing the Epileptogenic Zone in Temporal Lobe Epilepsies 2010 ·Journal of Nuclear Medicine ·Adrien Didelot, François Mauguı̀ere, Jérôme Redouté, Sandrine Bouvard, Amélie Lothe, Anthonin Reilhac, Alexander Hammers, Nicolas Costes, Philippe Ryvlin	37
16	5-HT1A gene promoter polymorphism and [18F]MPPF binding potential in healthy subjects: a PET study 2010 ·Behavioral and Brain Functions ·Amélie Lothe, Claudette Boni, Nicolas Costes, Sandrine Bouvard, Philip Gorwood, F. Lávenne, (unknown), Philippe Ryvlin	9
17	Brainstem changes in 5-HT_1A receptor availability during migraine attack 2010 ·Cephalalgia ·Geneviève Demarquay, Amélie Lothe, (unknown), Nicolas Costes, Gérard Mick, François Mauguı̀ere, Philippe Ryvlin	44
18	Association between triallelic polymorphism of the serotonin transporter and [18F]MPPF binding potential at 5-HT1A receptors in healthy subjects 2009 ·NeuroImage ·Amélie Lothe, Claudette Boni, Nicolas Costes, Philip Gorwood, Sandrine Bouvard, Didier Le Bars, F. Lávenne, Philippe Ryvlin	19
19	PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy 2008 ·Brain ·Adrien Didelot, Philippe Ryvlin, Amélie Lothe, Isabelle Merlet, Alexander Hammers, François Mauguı̀ere	51
20	Comorbidity between temporal lobe epilepsy and depression: a [18 F]MPPF PET study 2008 ·Brain ·Amélie Lothe, Adrien Didelot, Alexander Hammers, Nicolas Costes, Mohamed Saoud, Frank Gilliam, Philippe Ryvlin	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact